Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Clinical Trial to Assess the Efficacy and Safety of a Primary Prevention Strategy for Cardiovascular Events in Patients With Inflammatory Rheumatic Diseases Based on the Use of Carotid Ultrasound

NCT07611747 is registered in ClinicalTrials.gov with Instituto de Investigación Marqués de Valdecilla as lead sponsor.

NCT NCT07611747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07611747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Clinical Trial to Assess the Efficacy and Safety of a Primary Prevention Strategy for Cardiovascular Events in Patients With Inflammatory Rheumatic Diseases Based on the Use of Carotid Ultrasound
Lead sponsor
Instituto de Investigación Marqués de Valdecilla
Phase
Phase 4
Overall status
Recruiting
Start date
April 22, 2026
Completion date
December 31, 2031
Enrollment
1,944 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, axial spondy, caridovascular disease, carotid artery diseases, psoriatic arthritis (psa), rheumatoid arthritis (ra), systemic lupus erythematosus (sle)